Real-World Retrospective Safety Analysis in Patients Treated with OnabotulinumtoxinA for Multiple Therapeutic Indications over Repeat Treatment Periods (S27.006)
Evaluate the real-world safety of onabotulinumtoxinA use over repeat treatment periods (TPs) in patients with concomitant multiple therapeutic indications.
Authors
- Atul Patel (ORCID: https://orcid.org/0000-0002-6575-2460)
- Kimberly Becker Ifantides (ORCID: https://orcid.org/0009-0006-5303-7992)
- Ritu Singh
- Kenneth Martinez (ORCID: https://orcid.org/0000-0001-7651-8023)
- Simona Battucci
- Grace Forde
- Ahunna Ukah
- Angeli Mayadev (ORCID: https://orcid.org/0000-0001-6034-0531)
- Christopher Rhyne (ORCID: https://orcid.org/0000-0002-4540-4485)
- Ziyad Ayyoub
- Mariana Nelson
- Benjamin M. Brucker (ORCID: https://orcid.org/0000-0003-1699-3871)
- Irina Yushmanova (ORCID: https://orcid.org/0009-0006-1872-8093)
- Theodore R. Brown
Institutions
- Rancho Los Amigos National Rehabilitation Center (US)
- AbbVie (United States) (US)
- Hinge Health (US)
- Neuroscience Institute (IT)
- EvergreenHealth (US)
- Pain and Rehabilitation Medicine (US)
- AbbVie (Japan)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210728
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00